DFB names Phyton president
DFB Pharmaceuticals has appointed Magnus Precht as the new president at Phyton, a company specialising in plant cell fermentation for the production of pharmaceutical which it acquired last year.
Archives for January 15, 2004
Rapid-response vaccines from Dow
Dow Chemical has started a new research product, with the support of the US government, that could hasten the time it takes to make vaccines in response to a new epidemic or biological attack.
BIO in favour of EU 'biosimilar' approach
The US Biotechnology Industry Organisation has come out in support of European legislation that it says will require extensive tests to be conducted on so-called 'biosimilar' versions of biological drugs.
Separating the wheat from the chaff in antibody research
A microarray developed by Protometrix has been used to characterise the interactions between an antibody-based drug and the proteome - a snapshot of all the proteins produced by a cell.
Bidders gather in MG chemicals auction
A US-based private equity firm is the latest to join the list of bidders for Dynamit Nobel, the chemicals business being sold by German chemicals and engineering group MG Technologies.
Asthma: much more than one disease
A study which has found significant differences between the adult and childhood forms of asthma suggests that pharmaceutical companies may have to rethink their approach to developing new drugs for the disease.